This NCI grant is for currently funded P50 specialized centers to submit revision applications. Its purpose is to accelerate cancer research by integrating novel technical approaches or instruments developed through the NCI Innovative Molecular Analysis Technologies (IMAT) program. This funding opportunity incentivizes independent validation and promotes the adoption of these emerging technologies for broader research. As a key component of the NCI IMAT program, the grant aims to foster interdisciplinary collaboration in developing innovative tools and methods, ultimately enabling significant advancements and accelerating scientific discovery in cancer research.
Opportunity ID: 337213
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-22-009 |
| Funding Opportunity Title: | Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.394 — Cancer Detection and Diagnosis Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jan 04, 2022 |
| Last Updated Date: | Jan 04, 2022 |
| Original Closing Date for Applications: | Sep 22, 2022 |
| Current Closing Date for Applications: | Sep 22, 2022 |
| Archive Date: | Oct 28, 2022 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $150,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Native American tribal organizations (other than Federally recognized tribal governments) City or township governments Others (see text field entitled “Additional Information on Eligibility” for clarification) Independent school districts Native American tribal governments (Federally recognized) Private institutions of higher education For profit organizations other than small businesses Small businesses State governments County governments Special district governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications (formerly called “competing revisions”) from currently funded NCI P50 specialized centers. The applicants should propose to expand upon original research question(s) from specific projects or otherwise accelerate progress for the parent study by incorporating a new technical approach or instrument developed through support from the NCI Innovative Molecular Analysis Technologies (IMAT) program. Awards from this FOA are meant to incentivize independent validation and accelerate the suitability of these emerging technologies for appropriate research communities. As a component of the NCI IMAT program, this FOA aims to promote interdisciplinary collaboration in the development of innovative tools and methods that enable cancer research and accelerate scientific discovery. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-22-009.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
OERWebmaster03@od.nih.gov Email:OERWebmaster03@od.nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 337213 Full Announcement-RFA-CA-22-009 -> RFA-CA-22-009-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH OER Webmaster OERWebmaster03@od.nih.gov Email: OERWebmaster03@od.nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-G | Use for due dates on or after January 25, 2022 | PKG00271220 | Mar 22, 2022 | Sep 22, 2022 | View |
Package 1
Mandatory forms
337213 RR_SF424_5_0-5.0.pdf
337213 PHS398_CoverPageSupplement_5_0-5.0.pdf
337213 RR_OtherProjectInfo_1_4-1.4.pdf
337213 PerformanceSite_4_0-4.0.pdf
337213 RR_KeyPersonExpanded_4_0-4.0.pdf
337213 PHS398_ResearchPlan_4_0-4.0.pdf
337213 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
337213 PHS_Additional_IndirectCosts_2_0-2.0.pdf
337213 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
